Hemostasis Clinical Trial
Official title:
A Prospective, Randomized, Double-blind, Phase II Study to Evaluate the Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Vascular, Hepatic, Soft Tissue, and Spinal Open Surgeries
This purpose of this clinical trial is to study the safety and efficacy of Topical Thrombin (Human) Grifols as an add-on treatment to help stop bleeding during vascular, liver, soft tissue, and spinal open surgical procedures. Approximately 180 subjects will be treated with either Topical Thrombin (Human) Grifols (120 subjects) or Bovine Thrombin JMI® (60 subjects). Subjects will be evaluated for identification of a target bleeding site (TBS) in which control of bleeding by standard surgical techniques is ineffective or impractical and requires an additional treatment to stop the bleeding. The Investigator (surgeon) will rate the intensity of bleeding at the TBS. Topical Thrombin (Human) Grifols or Bovine Thrombin JMI will then be applied to the TBS and the amount of bleeding at the TBS will be examined.
This is a prospective, randomized, double-blind, controlled, Phase II study to evaluate the safety and efficacy of Topical Thrombin (Human) Grifols as an adjunct to hemostasis during vascular (IG1202-A), hepatic (IG1202-B), soft tissue (IG1202-C), and spinal (IG1202-D) open surgical procedures. Approximately 180 subjects will be randomized into 1 of 2 treatment groups in a 2:1 ratio: Topical Thrombin (Human) Grifols (120 subjects) or Bovine Thrombin JMI (60 subjects) among the 4 types of surgeries. Randomized subjects will be evaluated for identification of a target bleeding site (TBS) in which control of bleeding by conventional surgical techniques (including suture, ligature and cautery) is ineffective or impractical and requires an adjunct treatment to achieve hemostasis. The Investigator will rate the intensity of bleeding at the TBS. Topical Thrombin (Human) Grifols or Bovine Thrombin JMI will be applied to the TBS and hemostasis will be assessed at various timepoints during a 5-minute observation period. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05335525 -
Post-market Clinical Investigation of the Angio-Sealâ„¢ VIP VCD (ANGIO-SEAL CLOSE)
|
||
Completed |
NCT02583854 -
Comparison Study of Compression Devices Used in Transradial Coronary Angiography
|
N/A | |
Recruiting |
NCT05977946 -
Delivering Transcutaneous Auricular Neurostimulation to Regulate Platelet Activity in Healthy Human Subjects
|
N/A | |
Completed |
NCT01388491 -
A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women
|
Phase 2 | |
Recruiting |
NCT04728087 -
ACCEL Absorbable Hemostat
|
N/A | |
Recruiting |
NCT05323448 -
Efficacy of ARISTA-AH for Restoring Hemostasis Following Posterior Long-segment Spinal Fusion.
|
N/A | |
Recruiting |
NCT06078735 -
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
|
N/A | |
Completed |
NCT03907111 -
Compare the Hemostatic Effectiveness of Chitosan Gauze With Traditional Gauze on Open Wound on 10 Participants.
|
N/A | |
Recruiting |
NCT05875272 -
Interchangeability of Arterial Coagulation and Venous Coagulation, in the Context of Cardiac Surgeries Under Cardiopulmonary Bypass, Using the DMDiv Hemochron Signature Elite
|
||
Completed |
NCT04593667 -
Randomized Study of Accelerated Radial Arterial Hemostasis
|
N/A | |
Completed |
NCT01252186 -
A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
|
Phase 2 | |
Terminated |
NCT00802633 -
Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
|
N/A | |
Completed |
NCT02034799 -
Phase IV Bioseal Study in Brain Tumor Surgery
|
Phase 4 | |
Terminated |
NCT03873168 -
Post-Market Evaluation of HEMOBLASTâ„¢ Bellows in Open Gynecological, Urological, ENT, Head, Neck, and Vascular Surgeries
|
||
Recruiting |
NCT04377490 -
Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy
|
||
Completed |
NCT00449410 -
Silent Cerebrovascular Lesion and Cognitive Decline Prevention by Cholesterol Lowering in Elderly AF Patients
|
Phase 4 | |
Completed |
NCT03873181 -
Post-Market Evaluation of HEMOBLASTâ„¢ Bellows in Laparoscopic Abdominal, Gynecological, and Urological Surgery
|
||
Completed |
NCT04660721 -
A Study Evaluating the Safety and Preliminary Efficacy of sFilm-FS in Controlling Parenchymal Bleeding During Elective Hepatic Surgery
|
Phase 1/Phase 2 | |
Recruiting |
NCT05653843 -
MANTIS Endoscopic Clipping Study
|
||
Completed |
NCT00658723 -
The Fibrin Patch Soft Tissue Study
|
Phase 2 |